Role Summary
We are looking for a strategic and results-driven Business Development Manager to lead the expansion of our business in the biotechnology sectors. This role is ideal for an individual with deep industry knowledge, a strong network, and a passion for driving business growth. The successful candidate will be responsible for identifying new opportunities, developing strategic partnerships, and increasing the company’s visibility across global markets.
Role Summary
Role Summary
We are seeking a motivated and enthusiastic candidate for the position of lab manager in the antibody field. The successful individual will be responsible for managing and developing lab staff to ensure the effective operation of the antibody lab, devising, and implementing strategies to resolve process improvement issues, and collaborating with other operators to assure efficient and accurate sample handling that meets client needs.
Key Responsibilities
Role Summary
The research associate will be responsible for the production of recombinant proteins, and play a critical role in the discovery/development of novel molecular reagents. We are looking for a motivated and enthusiastic individual.
Key Responsibilities
Role Summary
The project manager is required to provide operational and project management support in the company and during external partnering events. This position plays an important role in the full lifecycle of mRNA therapeutics development from researching, creating new opportunities and building relationships with current/potential clients and strategic partners, providing them with effective solutions, supervising progress project, and managing records and data documents.
Key Responsibilities
As the annual meeting of the Antibody Society, the Antibody Engineering & Therapeutics has been recognized as one of the top antibody engineering conferences for accelerating next-generation antibodies to commercial success. The latest science and research on antibody engineering, design and selection diving into critical topics including Neurodegenerative Diseases, Tumor Microenvironment in Antibody Therapy, Antibody Immune Agonist, Bi-Specifics, ADCs, Protein-Based Degraders, Immuno-oncology, T-Cells, VHH and much more...
Recent scientific developments, particularly in antibody engineering, have led to numerous innovations in cancer immunotherapy and one of the most promising innovations has been the development of bispecific antibodies, as bispecific drugs make huge waves in multiple myeloma and lymphoma, so much so that they threaten cell therapy in multiple myeloma.
The 2025 NIH Spring Research Vendor Fair is a premier event that brings together leading researchers, innovative contract research organizations, and cutting-edge technology providers in the biomedical research ecosystem. This comprehensive marketplace offers an unparalleled opportunity for professionals to explore the latest advancements in clinical research, discover breakthrough technologies, and network with industry experts from across the United States.
In 2025, the spotlight is on neurodegenerative drug development, driven by the triumph of Lecanemab and Donanemab, coupled with rapid advancements to enable presymptomatic diagnosis, reinvigorating the space with new targets, modalities, and technologies. Meanwhile significant advancements to target the likes of α-synuclein, NLRP3 and GBA suggest only a matter of time until a disease-modifying therapy emerges on the scene for Parkinson’s too.
At Johns Hopkins, experts across various disciplines have come together to achieve a new level of precision in health care. Combining the knowledge of specialists from one of the world’s pre-eminent academic medical centers, renowned public health scholars and some of the best systems engineers on planet - Johns Hopkins in Health is continuing to explore and develop precision medicine approaches that will lead to quicker diagnoses, improved treatment and better outcomes. Johns Hopkins School of Medicine was awarded $335M from the National Institutes of Health in 2017.